Altered luminal accessory protein regulation of mutant cardiac ryanodine receptors as a putative mechanism of sudden cardiac death

Physiology 2015 (Cardiff, UK) (2015) Proc Physiol Soc 34, PC013

Poster Communications: Altered luminal accessory protein regulation of mutant cardiac ryanodine receptors as a putative mechanism of sudden cardiac death

C. E. Maxwell1, S. Mukherjee1, A. J. Williams1, N. L. Thomas1

1. School of Medicine (IMEM), Cardiff University, Cardiff, United Kingdom.

View other abstracts by:


Human cardiac ryanodine receptors (hRyR2) play an indispensible role in excitation-contraction coupling, allowing Ca2+ to pass from the sarcoplasmic reticulum (SR), into the cytoplasm of cardiomyocytes. These Ca2+ release channels form quaternary complexes with luminal accessory proteins calsequestrin (CSQ2), junctin (JUN) and triadin (TRD1), which are thought to regulate the response of hRyR2 to changes in luminal Ca2+ within the SR1. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is an arrhythmogenic disorder, caused by mutations in hRyR22 and CSQ23 genes and defective channel sensing of cytosolic and luminal Ca2+ plays an important role in disease pathogenesis4,5. Given the proposed role of CSQ2 and JUN in modulating the response of hRyR2 channels to activating Ca2+, altered association or dysfunctional regulation by these accessory proteins could be a contributing factor in the aberrant Ca2+ release identified in CPVT-linked mutant hRyR2. In this investigation we examine the interaction and response of wild-type (WT) and CPVT-linked mutant (A4556T and N4104K) eGFP-hRyR2 channels to CSQ2 and JUN co-expression in HEK293 cells. Luminal Ca2+ effects were monitored by examination of spontaneous Ca2+ release (SCR) events4 in fluo-3 loaded cells using confocal microscopy. Interaction with hRyR2 was assessed using pixel co-localisation of the co-expressed eGFP-hRyR2 with Alexa-594 labelled CSQ/JUN in fixed cells. All values are given as mean±SEM and analysed using one-way analysis of variance and a tukey-kramer post-hoc test (GraphPad Prism). Demonstrating functional heterogeneity between hRyR2 mutations, A4556T-hRyR2 displayed a similar pattern of SCR to WT, whilst N4104K-hRyR2 displayed a remarkably altered profile characterised by an increased frequency of events (WT 2.1±0.15 vs. NK 8.1±1.5 events/min, p<0.001 n=14) and decreased amplitude (ΔF/F0 WT 1.59±0.16 vs NK 0.79±0.08, p<0.05 n=12). Co-expression with CSQ2 (either in the presence or absence of JUN) had inhibitory effects on WT and N4104K-hRyR2, increasing inter-event duration (WT 36±3.69 vs NK 7.31±0.96 secs, p<0.001 n=13), thereby decreasing SCR event frequency (WT 1.34±0.13 vs NK 3.10±0.29 events/min, p<0.001 n=14), yet this inhibitory effect was not observed with A4556T-hRyR2 (AT+CSQ2 2.43±0.28 vs AT only 2.37±0.29 events/min n=14), suggesting that this CPVT mutant is unable to be regulated by this accessory protein. In agreement with this, immunofluorescent co-incident pixel counting suggested reduced CSQ2 and JUN association with A4556T-hRyR2 compared to WT (for example, WT 93%±1.46 vs AT 80%±3.0, p<0.05 n=12 (CSQ2 association in cells expressing hRyR2+CSQ2+JUN), whereas association with N4104K-hRyR2 was unchanged (85%±6.75). This suggests that A4556T affects hRyR2 regulation by CSQ2, possibly as a result of defective protein-protein interaction.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type